Dovitinib
Search documents
Allarity Therapeutics(ALLR) - Prospectus(update)
2023-06-30 21:23
As filed with the Securities and Exchange Commission on June 30, 2023. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Allarity Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Delaware 2834 87-2147982 (I.R.S. Employer Identification No.) Classification Code Number) 24 School Street, 2n ...
Allarity Therapeutics(ALLR) - Prospectus(update)
2023-04-17 12:08
As filed with the Securities and Exchange Commission on April 17, 2023. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Allarity Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 87-2147982 (Primary Standard Industrial Classification Code Number) 24 School Street, 2nd Floor Boston, MA 02108 Telephone: ...
Allarity Therapeutics(ALLR) - Prospectus
2023-03-14 10:25
As filed with the Securities and Exchange Commission on March 14, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Allarity Therapeutics, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2834 87-2147982 (Primary Standard Industrial Classification Code Number) 24 School Street, 2nd Floor Boston, MA 02108 Telephon ...